← 返回事件
持续讨论商业

Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy

图:CNBC Business

发生了什么

The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.

摘要按规则整理自下方来源原文

来源